Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
about
Direct stimulation of human fibroblasts by nCeO2 in vitro is attenuated with an amorphous silica coatingRabex-5 is a lenalidomide target molecule that negatively regulates TLR-induced type 1 IFN productionCerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Nanoparticle delivery of curcumin induces cellular hypoxia and ROS-mediated apoptosis via modulation of Bcl-2/Bax in human neuroblastoma.Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization.
P2860
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
@ast
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
@en
type
label
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
@ast
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
@en
prefLabel
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
@ast
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
@en
P2093
P2860
P1476
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
@en
P2093
Carl Y Sasaki
David Tweedie
Emmette R Hutchison
Erez Eitan
Hasan Celik
James Raymick
Mark P Mattson
Nigel H Greig
Paritosh Ghosh
Richard G Spencer
P2860
P304
P356
10.1016/J.EXPNEUROL.2015.08.008
P407
P577
2015-08-13T00:00:00Z